A retrospective observational study of ibrutinib in chronic lymphocytic leukaemia in a real-life setting in France using the national claims database (OSIRIS)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
A retrospective observational study of ibrutinib in chronic lymphocytic leukaemia in a real-life setting in France using the national claims database (OSIRIS) ; volume:103 ; number:8 ; day:5 ; month:7 ; year:2024 ; pages:2969-2981 ; date:8.2024
Annals of hematology ; 103, Heft 8 (5.7.2024), 2969-2981, 8.2024
- Creator
-
Choquet, Sylvain
Marchal, Clarisse
Deygas, Floriane
Deslandes, Marine
Macher, Nahid
Pouvourville, Gérard de
Levy, Vincent
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00277-024-05859-w
- URN
-
urn:nbn:de:101:1-2410122125438.056626076088
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Choquet, Sylvain
- Marchal, Clarisse
- Deygas, Floriane
- Deslandes, Marine
- Macher, Nahid
- Pouvourville, Gérard de
- Levy, Vincent
- SpringerLink (Online service)
Other Objects (12)
Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis
Revealing a phenotypical appearance of ibrutinib resistance in patients with chronic lymphocytic leukaemia by flow cytometry
Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Neutrophil biology in chronic lymphocytic leukaemia and infections
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia
Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
Expert consensus on the management of chronic lymphocytic leukaemia in Asia
Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis
Revealing a phenotypical appearance of ibrutinib resistance in patients with chronic lymphocytic leukaemia by flow cytometry
Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Neutrophil biology in chronic lymphocytic leukaemia and infections
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia
Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
Expert consensus on the management of chronic lymphocytic leukaemia in Asia
Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis
Revealing a phenotypical appearance of ibrutinib resistance in patients with chronic lymphocytic leukaemia by flow cytometry
Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Neutrophil biology in chronic lymphocytic leukaemia and infections
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia
Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib